NIGHTSTAR THERAPEUTICS PLC's ticker is NITE and the CUSIP is 65413A101. A total of 30 filers reported holding NIGHTSTAR THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $10,210,000 | – | 499,747 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,772,846 | $21,857,000 | 0.95% |
| NEA Management Company, LLC | 714,285 | $9,371,000 | 0.39% |
| PFM Health Sciences, LP | 979,393 | $12,850,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 134,965 | $1,771,000 | 0.23% |
| Partner Investment Management, L.P. | 10,038 | $132,000 | 0.15% |
| Tourbillon Capital Partners, L.P. | 170,952 | $2,243,000 | 0.08% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 111,571 | $1,464,000 | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 34,169 | $448,000 | 0.04% |
| Alyeska Investment Group, L.P. | 100,000 | $1,312,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,419,800 | $46,851,000 | 0.01% |